Drugs in Sport
Performance-Enhancing Drugs in Sport
Performance-enhancing drugs (PEDs) are substances that athletes take to improve their physical or psychological output in training or competition. Most PEDs are prohibited by the World Anti-Doping Agency (WADA) and the governing bodies of individual sports. The use of prohibited substances is considered cheating because it undermines the principle of fair competition and often poses serious health risks to the performer. Despite this, doping remains a persistent problem across numerous sports at elite level.
Why Performers Use Drugs
OCR requires students to understand the reasons why sports performers use performance-enhancing drugs. The most fundamental driver is the desire to gain a competitive advantage: in high-level sport, where the difference between winning and losing can be fractions of a second or tiny increments in strength or endurance, a substance that delivers even a marginal performance improvement may be the difference between a gold medal and obscurity. Linked to this is the pressure of financial reward: elite sport is a career, and success brings sponsorship, prize money and media contracts. Where the incentive to win is enormous, the temptation to use any available means is correspondingly strong.
A second cluster of reasons involves cultural and peer pressure. If a performer believes that their competitors are using prohibited substances — creating what they perceive as an uneven playing field — they may feel compelled to use them simply to compete on the same terms. Within some sporting environments, doping may be tacitly encouraged by coaches, management or team culture, making it difficult for an individual to refuse. A win-at-all-costs culture, reinforced by media attention and commercial pressure, can erode the ethical barriers that would otherwise constrain behaviour. Finally, some performers use drugs not to win but simply to recover from injury more quickly, to train harder, or to manage the physical demands of a very high-performance training schedule.
Performers use PEDs to gain a competitive advantage, because of financial incentives, due to peer pressure or a win-at-all-costs culture, or to recover more quickly and train harder. OCR requires knowledge of exactly three PED categories: anabolic steroids, beta blockers and stimulants.
WADA publishes an annually updated prohibited list covering hundreds of substances across every sport. Athletes bear strict liability — a positive test result leads to a ban regardless of whether the performer knew they had taken the substance.
Anabolic Steroids
Anabolic steroids are synthetic hormones that accelerate the development of muscle mass and reduce recovery time between training sessions. They are most commonly associated with power-based sports — such as weightlifting, shot put, sprinting or rugby — where muscle mass is a direct determinant of performance. By allowing performers to train harder and recover faster, anabolic steroids provide a substantial competitive advantage. Side effects include liver damage, cardiovascular disease, hormonal disruption (including effects on secondary sexual characteristics), and in adolescent users, premature closure of growth plates, which can permanently reduce adult height.
Beta Blockers
Beta blockers reduce heart rate, lower muscle tension and decrease blood pressure by blocking the effects of adrenaline. In sports requiring extreme precision — such as archery, shooting or snooker — a reduced heart rate and steadier hand provides a direct performance advantage, as even a small tremor can affect accuracy. Beta blockers are prohibited by WADA in these specific sports because they provide an unfair advantage. Side effects include nausea, weakness and potentially dangerous cardiac problems. They should only be used under medical prescription.
Stimulants
Stimulants are substances that increase alertness, reduce the sensation of fatigue and heighten aggression and competitiveness. They can improve reaction time and allow a performer to sustain high-intensity effort for longer. Sports such as sprint cycling or combat sports, where aggression and alertness are direct performance assets, have seen stimulant misuse. Side effects include elevated heart rate, anxiety, insomnia and in severe cases cardiac arrest. Stimulants are banned in competition by most governing bodies.
Anabolic steroids benefit power and strength athletes (e.g. a shot-putter who needs greater muscle mass and faster recovery). Beta blockers benefit precision performers (e.g. an archer whose accuracy is affected by a raised heart rate under competition pressure). Stimulants benefit high-speed or combat sport athletes (e.g. a sprint cyclist who needs maximum alertness and aggression over a short burst of effort). Matching the PED to the sport type and explaining the mechanism is the key skill tested in 1-mark Identify and 3-mark Describe questions on this topic.
Impact of Drug Use on Performers
The impact of PED use on individual performers is both physical and social. On the physical side, all three PED categories carry significant health risks: liver damage and cardiovascular disease (anabolic steroids), cardiac problems and weakness (beta blockers), and cardiac arrest or insomnia (stimulants). Beyond health, performers who are caught face bans from competition, fines, and the loss of medals and records. Reputational damage can be permanent — a performer’s entire career may be overshadowed by a doping conviction, affecting future coaching roles, sponsorship opportunities and public standing long after retirement.
Impact of Drug Use on Sport Itself
For sport as a whole, high-profile doping scandals damage credibility: if spectators suspect that results are determined by chemistry rather than talent and effort, they lose trust in the sport. This can reduce attendance, television audiences and sponsorship revenue — feeding back through the golden triangle to reduce the resources available to all performers, clean or otherwise. Sport’s value as a positive social model — promoting health, effort and fair competition — is also undermined when doping becomes associated with a discipline. Governing bodies and anti-doping agencies must invest heavily in testing programmes, which diverts resources from development and participation.
Some performers argue that if everyone is doping, using PEDs simply restores a level playing field. This reasoning should be challenged. First, not all athletes dope — those who refuse are placed at a systematic disadvantage. Second, access to the safest and most effective doping protocols depends on resources, meaning wealthier athletes and nations dope more effectively than poorer ones — an inequality within an inequality. Third, normalising PED use accelerates health risks for all performers by creating a race to ever-higher levels of doping. A strong 6-mark answer will recognise this argument, acknowledge why it holds superficial appeal, and then dismantle it with these counter-points.